Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Enlivex Therapeutics Ltd. Audit Report / Information 2019

Jul 17, 2019

6778_rns_2019-07-17_0e6bf088-bf1f-4299-b096-3e35a625653a.htm

Audit Report / Information

Open in viewer

Opens in your device viewer

_________ false

�������� ��������� ��"� 2 365
ENLIVEX THERAPEUTICS LTD
Corporation no: 514716489 12568
- - -
Israel Securities Authority Tel Aviv Stock Exchange C307 ( Public ) Reported via MAGNA: 17/07/2019
www.isa.gov.il www.tase.co.il Reference: 2019-02-073381 Time of broadcast: 12:15 12:13:45

Initial Details of Accountant

As of the date of this report, the details of the corporation's accountant are as follows:

1. Name of accountant: BKR | Yarel + Partners

2. Date on which he began his term of office: 17/03/2019

3. Address: 1 Nirim st., Tel-Aviv 6706036, Israel
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 25/06/2019
Address: Einstein 14 , NES-ZIONA 7403618   , ISRAEL Tel: 02-6708072 , Fax: 02-6708070
E-mail address: [email protected]   Company site: www.enlivex.com
Previous names of reporting entity:
Name of the Signatory: SHLOSBERGER SHACHAR Position of Signatory in the reporting corporation: Chief Financial Officer Name of Employer Company: Enlivex thetraputics R&D
Address: Nachal Dan 19 , Qiryat Uno 61580 Telephone: 054-4617610 Facsimile: - E-mail: [email protected] 2
ISRAEL